161 related articles for article (PubMed ID: 10439526)
1. Pyoderma gangrenosum with secondary pyarthrosis following propylthiouracil.
Darben T; Savige J; Prentice R; Paspaliaris B; Chick J
Australas J Dermatol; 1999 Aug; 40(3):144-6. PubMed ID: 10439526
[TBL] [Abstract][Full Text] [Related]
2. A case of propylthiouracil-induced pyoderma gangrenosum associated with antineutrophil cytoplasmic antibody.
Hong SB; Lee MH
Dermatology; 2004; 208(4):339-41. PubMed ID: 15178918
[TBL] [Abstract][Full Text] [Related]
3. ANCA positive propylthiouracil induced pyoderma gangrenosum.
Gungor K; Gonen S; Kisakol G; Dikbas O; Kaya A
J Endocrinol Invest; 2006 Jun; 29(6):575-6. PubMed ID: 16840840
[No Abstract] [Full Text] [Related]
4. [Neutrophilic dermatosis associated with propylthiouracil-induced p-ANCA (p-antineutrophil cytoplasmic antibodies)].
Boulenger-Vazel A; Kupfer-Bessaguet I; Gouedard C; Leberre R; Leroy JP; Sonnet E; Desvignes O; Misery L; Sassolas B
Ann Dermatol Venereol; 2005 Jan; 132(1):27-31. PubMed ID: 15746603
[TBL] [Abstract][Full Text] [Related]
5. [Pyoderma gangrenosum associated with anti-proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) induced by propylthiouracil].
Coster A; Dargent JL; de Visscher N; Levecque P; Roquet-Gravy PP
Ann Dermatol Venereol; 2017 May; 144(5):368-373. PubMed ID: 28291538
[TBL] [Abstract][Full Text] [Related]
6. Polyarthritis with perinuclear antineutrophil cytoplasmic antibody and Pyoderma gangrenosum. Report of a case.
Porteau-Cassard L; Marc V; Dromer C; Fournié B
Rev Rhum Engl Ed; 1997 Dec; 64(12):847-8. PubMed ID: 9476276
[TBL] [Abstract][Full Text] [Related]
7. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
[TBL] [Abstract][Full Text] [Related]
8. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
Noh JY; Asari T; Hamada N; Makino F; Ishikawa N; Abe Y; Ito K; Ito K
Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496
[TBL] [Abstract][Full Text] [Related]
9. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
10. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
[TBL] [Abstract][Full Text] [Related]
11. Koebner phenomenon in an ANCA-positive patient with pyoderma gangrenosum.
Papi M; Didona B; Chinni LM; Gobello T; Mazzanti C; De Pità O; Cavalieri R
J Dermatol; 1997 Sep; 24(9):583-6. PubMed ID: 9350105
[TBL] [Abstract][Full Text] [Related]
12. Propylthiouracil-induced antineutrophil cytoplasmic antibody positive vasculitis clinically mimicking pyoderma gangrenosum.
Wakamatsu K; Mitsuhashi Y; Yamamoto T; Tsuboi R
J Dermatol; 2012 Aug; 39(8):736-8. PubMed ID: 22132781
[No Abstract] [Full Text] [Related]
13. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K
Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312
[TBL] [Abstract][Full Text] [Related]
14. Recurrent episodes of arthritis in a hyperthyroid patient.
Tan F; Nam TQ; Lee KO; Cheah WK; Mukherjee JJ
Singapore Med J; 2006 Feb; 47(2):163-5. PubMed ID: 16435062
[TBL] [Abstract][Full Text] [Related]
15. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A
Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
Huang CN; Hsu TC; Chou HH; Tsay GJ
J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
[TBL] [Abstract][Full Text] [Related]
17. Pyoderma gangrenosum associated with c-ANCA (h-lamp-2).
Hoffman MD
Int J Dermatol; 2001 Feb; 40(2):135-7. PubMed ID: 11328397
[No Abstract] [Full Text] [Related]
18. [Antineutrophil cytoplasmic antibody (Anca)-associated autoimmune disease induced by propylthiouracil].
Pietszkowski NC; Carvalho GA; Souza HN; Werka CR; Borazo LA; Graf H; Carvalho Md
Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):136-41. PubMed ID: 17435868
[TBL] [Abstract][Full Text] [Related]
19. A successful pregnancy and delivery case of Graves' disease with myeloperoxidase antineutrophil cytoplasmic antibody induced by propylthiouracil.
Yamashita Y; Yamane K; Fujikawa R; Okubo M; Kohno N
Endocr J; 2002 Oct; 49(5):555-9. PubMed ID: 12507274
[TBL] [Abstract][Full Text] [Related]
20. Possibly propylthiouracil-induced antineutrophilic cytoplasmic antibody-associated vasculitis manifested as blood coagulation disorders: A case report.
Yi XY; Wang Y; Li QF; Li R; Yang SM; Zhou GQ; Wang ZH
Medicine (Baltimore); 2016 Oct; 95(41):e5068. PubMed ID: 27741122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
